Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Flavonoid Derivatives as New Potent Inhibitors of Cysteine Proteases: An Important Step toward the Design of New Compounds for the Treatment of Leishmaniasis

Version 1 : Received: 18 November 2022 / Approved: 21 November 2022 / Online: 21 November 2022 (06:29:51 CET)

A peer-reviewed article of this Preprint also exists.

Lourenço, E.M.G.; Di Iório, J.F.; da Silva, F.; Fialho, F.L.B.; Monteiro, M.M.; Beatriz, A.; Perdomo, R.T.; Barbosa, E.G.; Oses, J.P.; de Arruda, C.C.P.; de Souza Júdice, W.A.; Rafique, J.; de Lima, D.P. Flavonoid Derivatives as New Potent Inhibitors of Cysteine Proteases: An Important Step toward the Design of New Compounds for the Treatment of Leishmaniasis. Microorganisms 2023, 11, 225. Lourenço, E.M.G.; Di Iório, J.F.; da Silva, F.; Fialho, F.L.B.; Monteiro, M.M.; Beatriz, A.; Perdomo, R.T.; Barbosa, E.G.; Oses, J.P.; de Arruda, C.C.P.; de Souza Júdice, W.A.; Rafique, J.; de Lima, D.P. Flavonoid Derivatives as New Potent Inhibitors of Cysteine Proteases: An Important Step toward the Design of New Compounds for the Treatment of Leishmaniasis. Microorganisms 2023, 11, 225.

Abstract

Leishmaniasis is a neglected tropical disease and affects more than 350 million people worldwide. However, there are no vaccines for humans, and current treatment is hampered due to its high cost, numerous side effects, and painful administration routes. Ending its epidemics by 2030 has become a United Nations goal, and the multitarget drug strategy emerges as a promising alternative. Flavonoids are an example of multitarget compounds and organic synthesis represents a tool to obtain high yields of these molecules. In our study, we synthesized 17 flavonoid analogs using a scalable, easy-to-reproduce, and inexpensive method. All compounds demonstrated an impressive inhibition capacity against rCPB2.8, rCPB3, and rH84Y, which are highly expressed in the amastigote stage, the target form of the parasite. Compounds 3c, f12a, and f12b stood out as effective against all isoforms and intermolecular interactions were investigated through a molecular modeling study. The compounds were highly potent against the parasite and demonstrated low cytotoxic action against mammalian cells. The results were pioneering, representing an advance in the investigation of the mechanisms behind the antileishmanial action of flavonoid derivatives. Furthermore, compounds have shown to be promising leads for the design of other cysteine protease inhibitors for the treatment of leishmaniasis diseases.

Keywords

synthesis; leishmaniasis; flavonoids; rCPB; molecular modelling.

Subject

Chemistry and Materials Science, Medicinal Chemistry

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.